Cargando…
A Study of Proton Pump Inhibitors and Other Risk Factors in Warfarin-Associated Gastrointestinal Bleeding
Background Warfarin users are at increased risk for gastrointestinal bleeding (GIB). History of GIB, stroke, cardiovascular or chronic kidney disease, age greater than 65 years, and drug interaction with proton pump inhibitors (PPI) have previously been identified as risk factors for GIB in warfarin...
Autores principales: | Tang, Jevon, Sharma, Umesh, Desai, Shreya, Molnar, Janos, Perlmuter, Lawrence, Feller, Axel, Shah, Pallavi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872495/ https://www.ncbi.nlm.nih.gov/pubmed/33585113 http://dx.doi.org/10.7759/cureus.12624 |
Ejemplares similares
-
A Difficult and Rare Case of Warfarin Refractory Antiphospholipid Syndrome Presenting With Catastrophic Antiphospholipid Syndrome Complicated by Gastrointestinal Bleeding
por: Lim, William, et al.
Publicado: (2021) -
Skipping the Drip: Intravenous Proton Pump Inhibitor Bolus Therapy Leads to Poor Outcomes in High-Risk Bleeding
por: Khan, Raja Samir, et al.
Publicado: (2020) -
An Exceptionally Rare Cause of Refractory Gastrointestinal Bleed: Choriocarcinoma Syndrome
por: Yoon, Jennifer, et al.
Publicado: (2021) -
Comparison of Oral versus Intravenous Proton Pump Inhibitors in Preventing Re-bleeding from Peptic Ulcer after Successful Endoscopic Therapy
por: Karim, Rashid, et al.
Publicado: (2020) -
Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits
por: Lué, Alberto, et al.
Publicado: (2016)